Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion

Anesthesiology

Volumn 106, Issue 5, 2007, Pages 924-934

  Kim, Kye Min ^a   Choi, Byung Moon ^b   Park, Si Won ^b   Lee, Soo Han ^b   Christensen, Lane V ^c   Zhou, Jiaye ^d   Yoo, Byung Hoon ^a   Shin, Hye Won ^f   Bae, Kyun Seop ^b   Kern, Steven E ^e   Kang, Sung Hong ^g   Noh, Gyu Jeong ^b,h  

^a Inje University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c UNIVERSITY OF UTAH   (United States)

^d Department of Electrical and Computer Engineering   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f Korea University College of Medicine   (South Korea)

^g Inje University   (South Korea)

^h NONE   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAFOL; ATROPINE; EPHEDRINE; LIPID EMULSION; PARACETAMOL; PROPOFOL; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ANESTHETIC RECOVERY; APNEA; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BISPECTRAL INDEX; BOLUS INJECTION; BRADYCARDIA; CAUSAL ATTRIBUTION; CLINICAL TRIAL; COMPARTMENT MODEL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; EUPHORIA; EXCITEMENT; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; INFUSION RATE; INVOLUNTARY MOVEMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MAXIMUM PLASMA CONCENTRATION; MICROEMULSION; NORMAL HUMAN; OPEN STUDY; PHASE 1 CLINICAL TRIAL; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; UNCONSCIOUSNESS; VOLUNTEER;

ADULT; AGED; ANESTHETICS, INTRAVENOUS; CROSS-OVER STUDIES; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPOFOL; SAFETY;

EID: 34247559140     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000265151.78943.af     Document Type: Article

References (21)

1. Han J, Davis SS, Washington C: Physical properties and stability of two emulsion formulations of propofol. Int J Pharm 2001; 215:207-20
2. Baker MT, Naguib M: Propofol: The challenges of formulation. ANESTHESIOLOGY 2005; 103:860-76
3. Morey TE, Modell JH, Shekhawat D, Grand T, Shah DO, Gravenstein N, McGorray SP, Dennis DM: Preparation and anesthetic properties of propofol microemulsions in rats. ANESTHESIOLOGY 2006; 104:1184-90
4. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ: The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. ANESTHESIOLOGY 1998; 88:1170-82
5. Gepts E, Camu F, Cockshott ID, Douglas EJ: Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66:1256-63
6. Coetzee JF, Glen JB, Wium CA, Boshoff L: Pharmacokinetic model selection for target controlled infusions of propofol: Assessment of three parameter sets. ANESTHESIOLOGY 1995; 82:1328-45
7. Vuyk J, Engbers FH, Burm AG, Vletter AA, Bovill JG: Performance of computer-controlled infusion of propofol: An evaluation of five pharmacokinetic parameter sets. Anesth Analg 1995; 81:1275-82
8. Beal S, Sheiner L: NONMEM User's Guides Part V Introductory Guide. San Francisco, NONMEM Project Group, University of California, 1992, p 48
9. Jonsson EN, Karlsson MO: Xpose: An S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 1999; 58:51-64
10. Green B, Duffull SB: What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004; 58:119-33
11. Bouillon T, Shafer SL: Does size matter? ANESTHESIOLOGY 1998; 89:557-60
12. Shapiro S, Wilk M, Chen H: A comparative study of various tests for normality. J Am Stat Assoc 1968; 63:1343-72
13. Royston P: Estimating departure from normality. Stat Med 1991; 10:1283-93
14. Hull CJ, Van Beem HB, McLeod K, Sibbald A, Watson MJ: A pharmacodynamic model for pancuronium. Br J Anaesth 1978; 50:1113-23
15. Holford NH, Sheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6:429-53
16. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS: Pharmacokinetics of propofol (Diprivan) in elderly patients. Br J Anaesth 1988; 60:146-50
17. Schuttler J, Ihmsen H: Population pharmacokinetics of propofol: A multicenter study. ANESTHESIOLOGY 2000; 92:727-38
18. Gan TJ, Glass PS, Sigl J, Sebel P, Payne F, Rosow C, Embree P: Women emerge from general anesthesia with propofol/alfentanil/nitrous oxide faster than men. ANESTHESIOLOGY 1999; 90:1283-7
19. Ward DS, Norton JR, Guivarc'h PH, Litman RS, Bailey PL: Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion. ANESTHESIOLOGY 2002; 97:1401-8
20. Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ: The influence of age on propofol pharmacodynamics. ANESTHESIOLOGY 1999; 90:1502-16
21. Bury RW, Breen KJ, Desmond PV, Raymond K, Mashford ML: Disposition of intravenous glycofurol: Effect of hepatic cirrhosis. Clin Pharmacol Ther 1984; 36:82-4